European Society for Medical Oncology (ESMOCongress Roche Analyst Audio Webcast Monday, 22 October 2018 Welcome Daniel O’Day, CEO Roche Pharmaceuticals

First Page		Document Content
Medicine Clinical medicine Cancer Tyrosine kinase receptors Breast cancer Atezolizumab ROS1 Triple-negative breast cancer Anaplastic lymphoma kinase Trastuzumab emtansine Entrectinib Metastatic breast cancer		European Society for Medical Oncology (ESMOCongress Roche Analyst Audio Webcast Monday, 22 October 2018 Welcome Daniel O’Day, CEO Roche Pharmaceuticals Add to Reading List Source URL: www.roche.com Download Document from Source Website File Size: 2,40 MB Share Document on Facebook

	Assessment RunLung Anaplastic Lymphoma Kinase (lu-ALK) Material The slide to be stained for lu-ALK comprised: 1. Appendix, 2. Tonsil, 3. Merkel cell carcinoma, 4. Anaplastic large cell lymphoma DocID: 1tVgY - View Document
	Wrangling Phosphoproteomic Data to Elucidate Cancer Signaling Pathways Mark L. Grimes1*, Wan-Jui Lee2, Laurens van der Maaten2, Paul Shannon3 1 Division of Biological Sciences, University of Montana, Missoula, Montana, U DocID: 1qMPs - View Document
	05-AUG:10 LUNG ACCRUAL REPORT - Open and Recently Closed Studies SWOG/ Support STUDY DocID: 1pz0X - View Document
	Blood Testing for EML4-ALK Fusion Transcripts in Non-Small Cell Lung Cancer Patients by ddPCR: A CLIA Lab Experience Hestia Mellert, PhD April 17th, 2016 DocID: 1pw0y - View Document
	2nd Meeting of the European Research Initiative on ALCL June 27 th – 28 th 2011 Vienna, Austria DocID: 1o28e - View Document